Tissue Engineering

Regentis Biomaterials Advances Cell-Free Knee Cartilage Implant, Targeting Major Market Gap

Regentis Biomaterials Advances Cell-Free Knee Cartilage Implant, Targeting Major Market Gap

Regentis Biomaterials is advancing GelrinC, a ready-to-use hydrogel implant for knee cartilage repair, addressing a U.S. market of approximately 470,000 annual cases lacking an approved off-the-shelf regenerative solution.

May 29, 2026
Regentis Biomaterials Targets Major Gap in Knee Cartilage Repair with Off-the-Shelf Implant

Regentis Biomaterials Targets Major Gap in Knee Cartilage Repair with Off-the-Shelf Implant

Regentis Biomaterials Ltd. is advancing GelrinC, a cell-free hydrogel implant for knee cartilage repair, which could address a significant unmet need in the U.S. market where no off-the-shelf regenerative solution currently exists.

May 28, 2026
BioStem Technologies to Present at LD Micro Invitational, Highlighting Regenerative Medicine Advances

BioStem Technologies to Present at LD Micro Invitational, Highlighting Regenerative Medicine Advances

BioStem Technologies will present at the 16th Annual LD Micro Invitational, showcasing its proprietary allograft technologies and expanding presence in regenerative medicine.

May 12, 2026